Trial Outcomes & Findings for Sedation and Pain (The Effect of IV Sedation on Pain Perception) (NCT NCT00853333)

NCT ID: NCT00853333

Last Updated: 2014-06-26

Results Overview

Mechanical Slide Algometer (www.decisionaidsonline.com), Range: "No Pain Sensation" (1) to " Most Intense Sensation Imaginable" (10) 10 point scale. Change Time Points: Baseline (no sedation), Sedation. Same Day Intervention.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

86 participants

Primary outcome timeframe

Sedation

Results posted on

2014-06-26

Participant Flow

Participant milestones

Participant milestones
Measure
Dexmedetomidine
Sedation Arm 1, Dose adjusted to Sedation Self-rating of 50% on Sedation Scale.
Midazolam
Sedation Arm 2, Dose adjusted to Sedation Self-rating of 50% on Sedation Scale.
Propofol
Sedation Arm 3, Dose adjusted to Sedation Self-rating of 50% on Sedation Scale.
Overall Study
STARTED
28
27
31
Overall Study
COMPLETED
28
27
31
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Sedation and Pain (The Effect of IV Sedation on Pain Perception)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dexmedetomidine
n=28 Participants
Midazolam
n=27 Participants
Propofol
n=31 Participants
Total
n=86 Participants
Total of all reporting groups
Age, Continuous
24.74 years
STANDARD_DEVIATION 4.47 • n=5 Participants
24.46 years
STANDARD_DEVIATION 4.64 • n=7 Participants
25.83 years
STANDARD_DEVIATION 5.41 • n=5 Participants
25.01 years
STANDARD_DEVIATION 4.84 • n=4 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
16 Participants
n=7 Participants
14 Participants
n=5 Participants
45 Participants
n=4 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
11 Participants
n=7 Participants
17 Participants
n=5 Participants
41 Participants
n=4 Participants
Region of Enrollment
United States
28 participants
n=5 Participants
27 participants
n=7 Participants
31 participants
n=5 Participants
86 participants
n=4 Participants

PRIMARY outcome

Timeframe: Sedation

Mechanical Slide Algometer (www.decisionaidsonline.com), Range: "No Pain Sensation" (1) to " Most Intense Sensation Imaginable" (10) 10 point scale. Change Time Points: Baseline (no sedation), Sedation. Same Day Intervention.

Outcome measures

Outcome measures
Measure
Dexmedetomidine
n=28 Participants
Midazolam
n=27 Participants
Propofol
n=31 Participants
Pain Rating Change
-0.253 units on a scale
Standard Error 0.168
0.762 units on a scale
Standard Error 0.171
-0.346 units on a scale
Standard Error 0.159

Adverse Events

Dexmedetomidine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Midazolam

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Propofol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Michael Froelich

University of Alabama at Birmigham

Phone: (205)975-0145

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place